Login
Toggle navigation
Videos
Categories
Trending
Acer CEO Explores the Future of AI-Powered PCs
10:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Chairman and Chief Executive Officer Jason Chen has been Chairman and CEO of Acer since 2017.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Exploring Cameroon's Gold Potential: A New Frontier in West African Mining
00:10:00
Behavioral Finance: Market Implications by Marise Bester | Marise Bester, Allan Gray
00:10:00
Jeff Ackert, BSc.President, CEO & Director of Cascade Copper Corp
00:10:00
ROCA Industry’s Ionuț Bindea Discusses Market Dynamics and Growth Potential | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Presentation by Kay Quinoa, CEO of Tier Two Minerals Limited
00:10:00
Arcadis Innovates with Automated Inspection of San Remo Bridge | Alan Brookes - Chief Executive Officer and Chairman of Arcadis
00:10:00
Emerging Markets Poised for Growth This Decade: Insights from Morgan Stanley's Multi-Asset Group
00:00:00
Damian Marron, CEO, Txcell
00:10:00
Driving Access and Equity: A CEO's Vision for Affordable Physical Therapy Care and Female Leadership in Healthcare| Sharon Vitti , CEO, ATI Physical Therapy Inc.
00:10:00
GenXone CEO Discusses Growth Plans and NewConnect Debut Success | Michał Kaszuba, CEO, GenXone SA.
00:10:00
Udayan Goyal: Leading FinTech Innovations and Global Investment Strategies | Udayan Goyal - Co-Founder and Managing Partner of Apis Partners
00:10:00
Exclusive Insight: A Conversation with Ng Chai Yong, CEO of Mah Sing